The FDA has approved Amneal Pharmaceuticals’ Alymsys (bevacizumab-maly) as a biosimilar of Roche’s blockbuster cancer drug Avastin.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.